No findings. The diff is clean on both advisory lenses: no introduced correctness bugs or actionable reuse, simplification, or efficiency issues found.

Reviewed renewal settlement, deadline races, and fragment-write accounting (`crates/core/src/multipart/stage.rs:1638`, `:1948`, `:2184`), the shared batch-size calculation (`crates/core/src/multipart.rs:5190`), and the accompanying regression tests.

Frozen evidence records CI passing, including all 89 staging tests. The lone mutation survivor at `crates/core/src/multipart/stage.rs:326` is equivalent: `3 + 2N` is always odd, so `> 500` and `>= 500` agree. Diff coverage was not measured; verification was green-only. No tests were rerun or target files changed.

<!-- pdca:leaf-complete -->
